Recent advancements in mechanistic Research, therapeutic Potential, and Structure-Activity relationships of Aurora kinase inhibitors in cancer therapies DOI
Ghanshyam Teli, Lalmohan Maji, Rohit Pal

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 154, P. 107976 - 107976

Published: Nov. 16, 2024

Language: Английский

Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment DOI Creative Commons

Terungwa H. Iorkula,

Osasere Jude-Kelly Osayawe,

Daniel A. Odogwu

et al.

RSC Advances, Journal Year: 2025, Volume and Issue: 15(5), P. 3756 - 3828

Published: Jan. 1, 2025

Pyrazolo[1,5- a ]pyrimidines are notable class of heterocyclic compounds with potent protein kinase inhibitor (PKI) activity, playing critical role in targeted cancer therapy.

Language: Английский

Citations

2
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship DOI
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 274, P. 116535 - 116535

Published: May 31, 2024

Language: Английский

Citations

12
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents DOI

B. Kumaraswamy,

K. Hemalatha, Rohit Pal

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 275, P. 116561 - 116561

Published: June 7, 2024

Language: Английский

Citations

11
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship DOI
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 152, P. 107696 - 107696

Published: Aug. 8, 2024

Language: Английский

Citations

9
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies DOI

I. Aayishamma,

Gurubasavaraja Swamy Purawarga Matada, Rohit Pal

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 279, P. 116831 - 116831

Published: Sept. 6, 2024

Language: Английский

Citations

8
Synthetic product-based approach toward potential antileishmanial drug development DOI
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar

et al.

European Journal of Medicinal Chemistry, Journal Year: 2023, Volume and Issue: 263, P. 115927 - 115927

Published: Nov. 11, 2023

Language: Английский

Citations

18
An updated literature on BRAF inhibitors (2018–2023) DOI
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra

et al.

Molecular Diversity, Journal Year: 2023, Volume and Issue: 28(4), P. 2689 - 2730

Published: July 20, 2023

Language: Английский

Citations

12
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, Molecular insights, and Structure-activity relationship DOI

Nimmagadda Venkata Satya Sai Aishwarya,

Gurubasavaraja Swamy Purawarga Matada, Rohit Pal

et al.

Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1321, P. 139655 - 139655

Published: Aug. 22, 2024

Language: Английский

Citations

4
Anticancer and antibacterial Activeness of fused Pyrimidines: Newfangled Updates DOI

Ayushi Bhatnagar,

Gangotri Pemawat

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 153, P. 107780 - 107780

Published: Sept. 3, 2024

Language: Английский

Citations

4
Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure–activity relationship DOI
Sindhuja Sengupta, Lalmohan Maji, Pronoy Kanti Das

et al.

Molecular Diversity, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 30, 2025

Language: Английский

Citations

0